Publication | Closed Access

Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer’s disease model

Molecular PharmacologyAlzheimer's DiseaseCurrent AdvancesDisease ModelMedicineBrain HealthPsychotropic MedicationNeuropharmacologyCognitive DeficitNeurologyNeurosciencePharmacologyNeurochemistryDrug Discovery